Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology

Abstract

A simple two-step drug encapsulation method was developed to obtain biocompatible magnetic nanocarriers for the potential targeted treatment of diverse diseases. The nanodevice consists of a magnetite core coated with chitosan (Chit@MNPs) as a platform for diclofenac (Dic) loading as a model drug (Dic-Chit@MNPs). Mechanistic and experimental conditions related to drug incorporation and quantification are further addressed. This multi-disciplinary study aims to elucidate the toxicological impact of the MNPs at hematological, vascular, neurological and behavioral levels. Blood compatibility assays revealed that MNPs did not affect either erythrosedimentation rates or erythrocyte integrity at the evaluated doses (1, 10 and 100 μg mL). A microscopic evaluation of blood smears indicated that MNPs did not induce morphological changes in blood cells. Platelet aggregation was not affected by MNPs either and just a slight diminution was observed with Dic-Chit@MNPs, an effect possibly due to diclofenac. The examined formulations did not exert cytotoxicity on rat aortic endothelial cells and no changes in cell viability or their capacity to synthesize NO were observed. Behavioral and functional nervous system parameters in a functional observational battery were assessed after a subacute treatment of mice with Chit@MNPs. The urine pools of the exposed group were decreased. Nephritis and an increased number of megakaryocytes in the spleen were observed in the histopathological studies. Sub-acute exposure to Chit@MNPs did not produce significant changes in the parameters used to evaluate neurobehavioral toxicity. The aspects focused on within this manuscript are relevant at the pre-clinical level providing new and novel knowledge concerning the biocompatibility of magnetic nanodevices for biomedical applications.

Magnetite Nanoparticles Functionalized with RNases against Intracellular Infection of Pseudomonas aeruginosa

“…When compared with bare nanoparticles, the presence of the immobilized RNases appears not to have a further impact on aggregation. The intermediate levels of aggregation found here for the nanobioconjugates have been reported previously for other nanomaterials [59,60]. Of initial concern for this study was the potential cytotoxicity of RNases [61].…”

Magneto-chemotherapy for cervical cancer treatment with camptothecin loaded Fe3O4 functionalized β-cyclodextrin nanovehicle

“…These effects may be associated with bioactive compounds released by the magnetic nanomaterials and the in vivo inuence on the metabolic processes of magnetic iron oxide once transported into the diseased cells. [7][8][9] The expenditure of conventional drugs from natural and chemical synthesis for tumor treatment has drawbacks such as the quick discharge of their therapeutic effect, short blood circulation, and non-target specicity that can damage normal cells, causing serious side effects. 10,11 Currently, improved drugs that incorporate nanoparticle-based remedies are emerging tools in nanopharmacology.…”

Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment

“…George et al studied the functionalised nanohybrid hydrogel using L-histidine (HIS) conjugated chitosan, phyto-synthesised zinc oxide nanoparticles (ZNPs) and dialdehyde cellulose (DAC) as a sustained drug delivery carrier for the polyphenol, plant-derived compounds—naringenin, quercetin and curcumin. Anticancer studies towards A431 cells (epidermoid carcinoma) exhibited excellent cytotoxicity with a 15 to 30-fold increase using the hybrid carrier, compared to the free polyphenol drugs [ 116 ].…”